Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China by Asia Insider June 18, 2020 June 18, 2020 0 FacebookTwitterPinterestLinkedinRedditEmail
Countries from Vietnam to Germany got test and trace right, so why didn’t England? by Asia Insider June 18, 2020 June 18, 2020 The government was shown how to contain coronavirus – but chose to prioritise centralised control … 0 FacebookTwitterPinterestLinkedinRedditEmail
